Apple F S, Bandt C M
Clinical Laboratories, Hennepin County Medical Center, Minneapolis, Minnesota 55415.
Am J Clin Pathol. 1988 Jun;89(6):794-6. doi: 10.1093/ajcp/89.6.794.
Tricyclic antidepressants (TCAs) are one of the major causes of death from drug ingestions. Because TCAs are highly tissue bound, it has been postulated that postmortem tissue release would give rise to elevated blood levels. This study examines the authors' experience with TCAs as a cause of death and the reliability of postmortem liver and blood levels. Postmortem liver and blood TCA levels (parent drug and active metabolite) were quantitated by high-pressure liquid chromatography (HPLC) and gas chromatography mass spectrometry (GC-MS). From 1977 through 1985 the number and percentage of deaths caused by TCA overdoses have remained constant in regard to the total number of deaths caused by poisonings and overdoses: range: 4-17; 5.6-20.2%, respectively. During a six-month period in 1986-1987, nine deaths were caused by six different TCAs. Substantial increases in blood TCA levels were observed as the postmortem interval increased. The mean liver and blood levels were as follows: 232 micrograms/g of tissue (SD, 168) and 6.2 mg/L (SD, 2.4). The liver to blood ratio for the nine cases was 37 (SD, 22):1. In comparison, in cases (n = 4) in which the causes of death were not TCA related but the patients were taking therapeutic doses of TCA, the mean liver and blood levels were 10.8 micrograms/g (SD, 6.0) and 0.26 mg/L (SD, 0.06), respectively. The liver to blood ratio of 39.2 (SD, 17.9): 1 was not different than in the overdose cases. This large tissue to blood gradient in both TCA overdose and therapeutic ingestion cases indicates that postmortem release of tissue-bound TCAs into the blood might falsely show elevated postmortem blood levels that could be indicative of a manner of death even in the nonoverdose, therapeutic ingestion. Thus, only liver TCA levels should be quantitated to specify the manner of death.
三环类抗抑郁药(TCAs)是药物摄入导致死亡的主要原因之一。由于三环类抗抑郁药与组织高度结合,据推测死后组织释放会导致血液水平升高。本研究考察了作者关于三环类抗抑郁药作为死因的经验以及死后肝脏和血液水平的可靠性。通过高压液相色谱法(HPLC)和气相色谱 - 质谱联用仪(GC - MS)对死后肝脏和血液中的三环类抗抑郁药水平(母体药物和活性代谢物)进行定量。从1977年到1985年,相对于中毒和药物过量导致的死亡总数,三环类抗抑郁药过量导致的死亡数量及百分比保持稳定:范围分别为4 - 17例;5.6% - 20.2%。在1986 - 1987年的六个月期间,六种不同的三环类抗抑郁药导致了9例死亡。随着死后间隔时间增加,观察到血液中三环类抗抑郁药水平大幅升高。肝脏和血液的平均水平如下:组织232微克/克(标准差,168),血液6.2毫克/升(标准差,2.4)。这9例病例的肝血比为37(标准差,22):1。相比之下,在死因与三环类抗抑郁药无关但患者正在服用治疗剂量三环类抗抑郁药的病例(n = 4)中,肝脏和血液的平均水平分别为10.8微克/克(标准差,6.0)和0.26毫克/升(标准差,0.06)。肝血比为39.2(标准差,17.9):1,与过量用药病例无差异。在三环类抗抑郁药过量和治疗性摄入病例中,这种组织与血液之间的大梯度表明,死后组织结合的三环类抗抑郁药释放到血液中可能会错误地显示死后血液水平升高,这可能表明即使在非过量、治疗性摄入的情况下的死亡方式。因此,只有肝脏三环类抗抑郁药水平应进行定量以确定死亡方式。